Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor
1996

Effective Treatment of Advanced Breast Cancer with Vinorelbine, Mitomycin C, and G-CSF

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): GV Kornekl, K Haider, W Kwasny, M Hejnal, M Radererl, S Meghdadil, D Burger, B Schneeweiss, D Depisch, W Scheithauer

Primary Institution: Vienna University Medical School

Hypothesis

The study aims to evaluate the efficacy and tolerance of vinorelbine, mitomycin C, and G-CSF in patients with advanced breast cancer.

Conclusion

The combination of vinorelbine, mitomycin C, and G-CSF shows excellent anti-tumor activity in advanced breast cancer.

Supporting Evidence

  • The overall response rate was 73%, with 22% achieving complete response.
  • Among previously untreated patients, 28% achieved complete response.
  • All nine patients with locally advanced disease were rated responsive.

Takeaway

This study tested a new treatment for advanced breast cancer and found that it worked really well for many patients.

Methodology

A phase II trial was conducted with 55 patients receiving vinorelbine, mitomycin C, and G-CSF, with evaluations of efficacy and toxicity.

Limitations

The study had a relatively small sample size and a short follow-up period.

Participant Demographics

Median age was 59 years, with 9 patients having locally advanced disease and 46 with distant metastases.

Statistical Information

Confidence Interval

95% confidence interval, 59-84%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication